94 results on '"Lip, G."'
Search Results
2. 36 Monocyte Subpopulations Counts and Associations with Global Longitudinal Strain in St-Elevation Myocardial Infarction Patients with Normal Ejection Fraction
3. Anticoagulant treatment is effective in atrial fibrillation
4. OC-024 Prolonged Platelet Activation in Patients with Acute Upper Gastrointestinal Bleeding: Abstract OC-024 Table 1
5. 043 MONOCYTE SUBPOPULATION COUNTS AND ASSOCIATIONS WITH LEFT VENTRICULAR EJECTION FRACTION POST ST ELEVATION MYOCARDIAL INFARCTION: Table 1
6. 202 MONOCYTE SUBSET PHENOTYPE IN CORONARY ARTERY DISEASE AND THEIR ASSOCIATIONS WITH MARKERS OF INFLAMMATION AND FIBRINOLYSIS
7. 242 EXPRESSION OF RECEPTORS TO INTERLEUKIN 6 AND ADHESION MOLECULES ON CIRCULATING MONOCYTE SUBSETS IN MYOCARDIAL INFARCTION
8. 243 MONOCYTE SUBPOPULATION COUNTS AND TNF ALPHA ASSOCIATIONS WITH CLINICAL OUTCOME POST ST ELEVATION MYOCARDIAL INFARCTION
9. Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis
10. Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study
11. PWE-161 Platelet activation in acute upper gastrointestinal bleeding
12. PMO-202 Use of the Blatchford score to identify low-risk upper gastrointestinal bleeds
13. PWE-162 Seasonal and diurnal variation in the presentation and severity of acute upper gastrointestinal bleeding
14. 053 Factors affecting quality of warfarin anticoagulation in patients with atrial fibrillation: insights from affirm
15. 054 Left ventricular geometry and outcome in patients with atrial fibrillation: insights from the affirm trial
16. 125 Monocyte subpopulation counts and functional characteristics predict adverse clinical events post ST elevation myocardial infarction: Abstract 125 Table 1
17. 058 The relationship of left atrial remodelling to atrial fibrillation burden in pacemaker population: Abstract 058 Table 1
18. 126 Dynamics of the three human monocyte subsets over 30 days in ST-elevation myocardial infarction: Abstract 126 Table 1
19. 115 Unique characteristics of CD14++CD16+ monocytes in patients with acute heart failure and implications for clinical outcome
20. 102 Ethnic differences in endothelial function in chronic heart failure
21. 115 Atrial high rate episodes and atrial fibrillation burden: do they have similar association with cardiac remodelling?
22. 146 Is there an association between thrombogenesis markers and atrial fibrillation burden in pacemaker population?
23. The angiome: a new concept in cancer biology
24. Soluble vascular endothelial growth factor receptor (VEGFR)-2 in macular oedema--a mechanism for regulating angiogenesis?
25. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
26. 131 Ethnic differences in 5 year outcome following percutaneous coronary intervention
27. 088 Is there any improvement in 3D and 2D echocardiography determined left atrial volume following continuous positive airway pressure treatment in patients with obstructive sleep apnoea?: Abstract 088 Table 1
28. The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage?
29. Review: combining 2 classes of blood pressure-lowering drugs has an approximately additive effect on systolic blood pressure
30. Lone atrial fibrillation: what do we know?
31. Managing the anticoagulated patient with atrial fibrillation at high risk of stroke who needs coronary intervention
32. The Birmingham rehabilitation uptake maximisation study (BRUM): a randomised controlled trial comparing home-based with centre-based cardiac rehabilitation
33. Inflammation and atrial fibrillation: cause or effect?
34. Left ventricular ejection fraction: are the revised cut-off points for defining systolic dysfunction sufficiently evidence based?
35. Endothelial progenitor cells, endothelial cell dysfunction and much more: observations from cardiac syndrome X
36. Atrial fibrillation--the growing epidemic
37. Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillation
38. The new NICE guideline on atrial fibrillation management
39. Management of atrial fibrillation
40. Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation
41. Ethnic differences in patient perceptions of heart failure and treatment: the West Birmingham heart failure project
42. ABC of antithrombotic therapy: Antithrombotic therapy in myocardial infarction and stable angina
43. ABC of antithrombotic therapy: Antithrombotic therapy for cerebrovascular disorders
44. ABC of antithrombotic therapy: Antithrombotic therapy for atrial fibrillation
45. Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma
46. Blood pressure measurement
47. Long term anticoagulation or antiplatelet treatment
48. ABC of heart failure: Management: digoxin and other inotropes, ß blockers, and antiarrhythmic and antithrombotic treatment
49. ABC of heart failure: Management: diuretics, ACE inhibitors, and nitrates
50. ABC of heart failure: Investigation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.